Complementary LC-MS/MS Proteomic Analysis of Uremic Plasma Proteins

Area of Science:

• Proteomics
• Clinical Mass Spectrometry
• Renal Disease Biomarkers

Background:

• Uremic plasma exhibits altered protein profiles compared to healthy individuals.
• Previous analyses utilized MALDI-TOF mass spectrometry for protein identification.

Purpose of the Study:

• To enhance protein identification in uremic plasma by incorporating LC-MS/MS analysis.
• To complement prior proteomic findings from MALDI-TOF mass spectrometry.
• To assess the applicability of LC-MS/MS in clinical proteomics.

Main Methods:

• Plasma samples from seven chronic kidney disease stage 5 patients and seven matched controls were analyzed.
• Proteins were separated using SDS-PAGE and HPLC after immunodepletion.
• Tryptic peptides were identified using LC-MS/MS.

Main Results:

• LC-MS/MS identified approximately twice as many increased proteins in uremic plasma compared to previous analyses.
• Identified proteins included complementary subunits of protein complexes, enhancing the proteomic landscape.
• The study demonstrated increased protein identifications with the addition of LC-MS/MS.

Conclusions:

• Mass spectrometry, particularly LC-MS/MS, is effective for analyzing complex plasma proteomes in clinical environments.
• LC-MS/MS, based on peptide sequence analysis, offers superior protein identification capabilities.
• The study confirms the feasibility and clinical utility of LC-MS/MS for diagnosing and monitoring kidney disease.